Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kerry Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.
Kerry Group PLC (KRYAY) Given $90.80 Consensus Price Target by Analysts
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kerry Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.
Analysts have set a 12-month consensus price objective of $90.80 for the company, according to Zacks. Zacks has also assigned Kerry Group PLC an industry rank of 102 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research downgraded shares of Kerry Group PLC from a “buy” rating to a “hold” rating in a report on Friday, April 28th.
Kerry Group PLC (NASDAQ:KRYAY) remained flat at $91.01 during midday trading on Friday. 160 shares of the company traded hands. The firm has a 50 day moving average of $88.50 and a 200 day moving average of $81.84. Kerry Group PLC has a 12 month low of $66.21 and a 12 month high of $91.96. The stock has a market capitalization of $16.02 billion and a price-to-earnings ratio of 26.40.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by [[site]] and is the sole property of of [[site]]. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at [[permalink]].
About Kerry Group PLC
Kerry Group plc is a provider of taste and nutrition solutions. The Company serves the food, beverage and pharmaceutical industries, and is a supplier of branded and customer branded foods to the Irish, the United Kingdom and selected international markets. The Company operates through two segments: Taste & Nutrition, and Consumer Foods.
Get a free copy of the Zacks research report on Kerry Group PLC (KRYAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com